NCT04640766View on ClinicalTrials.gov

Process-instructed Self Neuro-Modulation (PRISM) for Attention Deficit/ Hyperactivity Disorder - Adults

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

July 26, 2021

Primary Completion Date

October 18, 2022

Study Completion Date

October 18, 2022

Conditions
Attention Deficit Hyper Activity
Interventions
DEVICE

PRISM

"The study will include 12 EEG-NF sessions, administered twice per week for a duration of 6 active weeks in total. Twice weekly sessions will be held on no-consecutive days. Each session will last approximately 30 minutes."

Trial Locations (1)

10016

NYU Langone Health, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT04640766 - Process-instructed Self Neuro-Modulation (PRISM) for Attention Deficit/ Hyperactivity Disorder - Adults | Biotech Hunter | Biotech Hunter